KDR and portal hypertension: Kinase insert domain receptor (KDR), also known as VEGF receptor-216–20, is an endothelial cell surface receptor that is abundantly expressed in portal hypertension but not in normal tissues, and has a central role in the regulation of portosystemic collateral development6–10, and pathological angiogenesis16–20, as we and other groups have previously demonstrated.